PAX6 mutation in association with ptosis, cataract, iris hypoplasia, corneal opacification and diabetes: a new variant of familial aniridia?
Background We report a family with ptosis, cataract, iris hypoplasia and gradual corneal opacification occurring in association with a PAX6 mutation. Design Case‐series. Participants Fourteen family members – 8 affected, 6 unaffected controls. Methods All participants underwent ophthalmological asse...
Saved in:
Published in | Clinical & experimental ophthalmology Vol. 41; no. 9; pp. 835 - 841 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Blackwell Publishing Ltd
01.12.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1442-6404 1442-9071 1442-9071 |
DOI | 10.1111/ceo.12109 |
Cover
Loading…
Summary: | Background
We report a family with ptosis, cataract, iris hypoplasia and gradual corneal opacification occurring in association with a PAX6 mutation.
Design
Case‐series.
Participants
Fourteen family members – 8 affected, 6 unaffected controls.
Methods
All participants underwent ophthalmological assessment, including best‐corrected visual acuity, slit‐lamp‐examination, pachymetry, endothelial cell‐count, tonometry and dilated fundoscopy. All subjects underwent anthropometry and assessment of glycaemic status. Genetic analysis of the PAX6 gene was performed.
Main Outcome Measures
Presence of ptosis, corneal, iris and lenticular changes, gycaemic and PAX6 status.
Results
All eight affected subjects had ptosis with reduced levator function, anterior polar cataracts, and corneal changes of variable severity – two patients had undergone penetrating keratoplasties, with graft histology revealing conjunctival cells on the cornea and severe fibroinflammatory change. Five patients had iris hypoplasia. One patient had aphakic glaucoma and another had hypoplastic optic discs. Four of the six controls had no ocular features of this syndrome, and two had isolated mild ptosis. There was no difference in height or body mass index between cases and family controls (p > 0.05), but Haemoglobin A1c was greater in the cases (median [interquartile range] 5.6(0.8) vs 5.1(0.3), p = 0.028). Genetic analysis confirmed a pathogenic PAX6 mutation in exon 12 (c1439delC) in all eight patients, but none of the controls.
Conclusion
This is the first report of this particular constellation of ocular signs occurring in association with a PAX6 mutation. There was no association with anthropometric features, but affected subjects had worse glycaemia than controls, which may be related to the known role of PAX6 in development of the pancreas. |
---|---|
Bibliography: | National Institute for Health Research (NIHR) istex:940561E8C297889491DBDEC9D32A3F30CF1D27E7 ark:/67375/WNG-182T7XN9-4 ArticleID:CEO12109 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1442-6404 1442-9071 1442-9071 |
DOI: | 10.1111/ceo.12109 |